About this article
Article Category: Review Paper
Published Online: Aug 11, 2025
Received: Oct 10, 2021
Accepted: Dec 12, 2021
DOI: https://doi.org/10.2478/sjecr-2021-0033
Keywords
© 2021 Suzana Popovic et al., published by Sciendo
This work is licensed under the Creative Commons Attribution-NonCommercial-NoDerivatives 4.0 International License.
Figure 1.

Mechanisms of HDPs antimicrobial activity
Mechanism of action | HDPs | Target organism | Reference |
Permeabilization of the outer and the inner membrane | HNP4 | ( |
|
Membrane dysfunction | Lactoferrin | ( |
|
Inhibition of cell wall synthesis | BMAP-28 | ( |
|
Polymixin E | ( |
||
RTD-1 | ( |
||
Mersacidin | ( |
||
Seminalplasmin | ( |
||
HNP-1 | ( |
||
hBD3 | ( |
||
Inhibition of DNA, RNA and protein synthesis | tPMP-1 and tPMP-2 | ( |
|
Pleurocidin | ( |
||
Apidaecins, oncocins | |||
Activation of the microbial autolytic systems | RTD-1 and RTD-2 | ||
Viral envelopes lysis | LL-37 | ( |
|
Interference with viral adsorption and/or entry into the cell | Dermaseptins | HSV1 | ( |
HNPs-1 - 3, HD-5 | HPV | ( |
|
HNP-1 | HSV1 | ( |
|
NP-1 | HSV2 | ( |
|
HD5 | HIV1 | ( |
|
β-defensin-2 and HBD-3 | HIV1 | ( |
|
Inhibition of replication | Melittin, Cecropin | HIV1 | ( |
Alpha-defensin-1 | HIV1 | ( |
|
β-defensin-2, HBD-3 | HIV1 | ( |
|
LL-37 | HIV1 | ( |
|
Blocking expression of viral genes | HNP-1 and HBD-2 | HIV1 | ( |
LL-37, mCRAMP | ( |
||
Retrocyclin 2 | H5N1 | ( |
|
HNP2, HDP | HSV2 | ||
Membrane lysis | Cecropin B, Dermaseptin | ( |
|
Ranalexin, Magainin II | ( |
||
Inhibition of fungal chitin synthase | Nikkomycins X and Z | ( |
|
Inhibition of sphingolipid synthesis | Aureobasidin A | ( |
|
Disruption of actin assembly and chitin delocalization | Aureobasidin A | ( |
|
Induction of reactive oxygen species | RsAFP2 | ( |
|
HsAFP1 | ( |
||
Induction of ion fluxes | DmAMP1 | ( |
|
Cell cycle progression impairment | RsAFP2 | ( |
|
Psd1 | |||
Membrane permeabilisation | NK-lysin | ( |
|
( |
|||
Oocyst development and sporozoite production | Magainin 2, Cecropin B | ( |
|
Membrane disruption, morphological changes, apoptosis induction | bLF | ( |
|